fig3
Figure 3. Mechanisms of action of stem cell therapy for myasthenia gravis. PD-L1: Programmed death ligand 1; IL-1RA: interleukin-1 receptor antagonist; IDO-1: indoleamine 2,3-dioxygenase 1; T regs: regulatory T cells; TGF-β: transforming growth factor beta; MSC: Mesenchymal stromal/stem cell. Created in BioRender. Windsor R (2026) https://BioRender.com/aqu0egm.
